MR imaging-guided prostate biopsy: technical features and preliminary results

Area of Science:

• Urologic Oncology
• Diagnostic Imaging
• Medical Technology

Background:

• Elevated prostate-specific antigen (PSA) levels often necessitate repeat prostate biopsies.
• Negative biopsies in the setting of rising PSA can cause patient and clinician frustration.
• Accurate diagnosis is crucial for timely prostate cancer (PCa) treatment.

Purpose of the Study:

• To evaluate the diagnostic performance of magnetic resonance imaging (MRI)-guided transrectal biopsy (MRGB).
• To determine if MRGB increases cancer detection rates in men with suspected PCa.
• To assess the feasibility and safety of MRGB in a clinical setting.

Main Methods:

• Twenty-three men with elevated PSA, suspicious MRI findings, and prior negative biopsies were included.
• MRGB was performed using a 1.5 Tesla MRI unit and specialized biopsy equipment.
• Procedures targeted suspicious areas identified on prebiopsy MRI.

Main Results:

• MRGB successfully identified suspicious areas in all 23 patients.
• The overall cancer detection rate for PCa was 80%.
• 90% of detected PCa cases were of intermediate aggressiveness, indicating effective identification of clinically relevant disease.

Conclusions:

• MRGB demonstrates significant potential to enhance prostate cancer detection.
• This technique can improve diagnostic accuracy in men with suspected PCa.
• Early and accurate diagnosis via MRGB facilitates prompt and appropriate treatment initiation.